NFE2L2 and multiple sclerosis: Tecfidera (dimethyl fumarate), a potent Nrf2 activator, has been approved for the treatment of multiple sclerosis (Gold et al., 2012), but long-term use of this drug can cause resistance and other side effects (Deeks, 2014).